Conducting studies of NOVO-NK’s COVID-19 killing mechanisms with National Masan Hospital, a subsidiary of Ministry of Health and Welfare.
최고관리자
0
729
07-06
On June 11th, the company signed a collaborative research contract with Masan Hospital, developing a novel treatment using NK cells.
On June 16th, both parties signed a collaboration research contract studying the anti virial effect of NK cell on COVID-19 that further specified the previous contract.
NovoCell Bio and Masan Hospital will effectively collaborate with each party’s expertise and promising data.
On June 16th, both parties signed a collaboration research contract studying the anti virial effect of NK cell on COVID-19 that further specified the previous contract.
NovoCell Bio and Masan Hospital will effectively collaborate with each party’s expertise and promising data.